Successful treatment of reactive hemophagocytic syndrome by plasmapheresis and high-dose γ-globulin in a patient with systemic lupus erythematosus

Abstract A 31-year-old woman who had been administered corticosteroid and immunosuppressive agents for systemic lupus erythematosus (SLE) without flare-up was diagnosed as having reactive hemophagocytic syndrome (HPS) with severe disseminated intravascular coagulation. The causative underlying disease was uncertain, but it was not the SLE itself. Her fulminant HPS with increased serum ferritin and inflammatory cytokines (sIL-2R, TNF-α, IL-6, and IFN-γ) was successfully treated with plasmapheresis and high-dose γ-globulin therapy.

[1]  M. Bessho,et al.  Therapy-related AML after successful chemotherapy with low dose etoposide for virus-associated hemophagocytic syndrome. , 1998, International journal of hematology.

[2]  D. Brenner,et al.  The mitochondrial permeability transition in cell death: a common mechanism in necrosis, apoptosis and autophagy. , 1998, Biochimica et biophysica acta.

[3]  Y. Murakawa,et al.  Reactive hemophagocytosis in systemic lupus erythematosus. , 1998, Internal medicine.

[4]  Y. Minamino,et al.  Successful treatment with cyclosporine in a case of hemophagocytic syndrome manifesting as severe liver dysfunction. , 1997, The American journal of the medical sciences.

[5]  J. Chen,et al.  Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. , 1997, The Journal of clinical investigation.

[6]  M. Yoshida,et al.  Prognostic factors of hemophagocytic syndrome in adults: analysis of 34 cases , 1997, European journal of haematology.

[7]  S. Imashuku,et al.  Differential diagnosis of hemophagocytic syndrome: underlying disorders and selection of the most effective treatment. , 1997, International journal of hematology.

[8]  M. Okano,et al.  Epstein‐Barr virus‐associated hemophagocytic syndrome and fatal infectious mononucleosis , 1996, American journal of hematology.

[9]  H. Tsuda,et al.  Successful treatment of virus‐associated haemophagocytic syndrome in adults by cyclosporin A supported by granulocyte colony‐stimulating factor , 1996, British journal of haematology.

[10]  D. Gill,et al.  High‐dose gamma‐globulin therapy in the reactive haemophagocytic syndrome , 1994, British journal of haematology.

[11]  P. Pitel,et al.  Intravenously administered immune globulin for the treatment of infection-associated hemophagocytic syndrome. , 1993, The Journal of pediatrics.

[12]  S. Hibi,et al.  Hypercytokinemia in Hemophagocytic Syndrome , 1993, The American journal of pediatric hematology/oncology.

[13]  S. Ha,et al.  The acute lupus hemophagocytic syndrome. , 1991, Annals of internal medicine.

[14]  P. Close,et al.  Viral-associated hemophagocytic syndrome. , 1990, Medical and pediatric oncology.